Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析

◆英語タイトル:Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME45129PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company’s product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Australia, Italy, New Zealand, and other Scandinavia regions (Sweden, Norway and Denmark). Tandem is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Tandem Diabetes Care Inc Company Overview
Tandem Diabetes Care Inc Company Snapshot
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Tandem Diabetes Care Inc – Pipeline Analysis Overview
Tandem Diabetes Care Inc – Key Facts
Tandem Diabetes Care Inc – Major Products and Services
Tandem Diabetes Care Inc Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Overview
AutoSoft XC
AutoSoft XC Product Overview
Next Generation Gswim
Next Generation Gswim Product Overview
t:connect Mobile – Biometric Authentication
t:connect Mobile – Biometric Authentication Product Overview
t:connect Mobile – Decision Support
t:connect Mobile – Decision Support Product Overview
t:connect Mobile – Health App Integration
t:connect Mobile – Health App Integration Product Overview
t:connect Mobile – Mobile Bolus
t:connect Mobile – Mobile Bolus Product Overview
t:sport
t:sport Product Overview
Tandem Diabetes Care Inc – Key Competitors
Tandem Diabetes Care Inc – Key Employees
Tandem Diabetes Care Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tandem Diabetes Care Inc, Recent Developments
Mar 02, 2020: Tandem Diabetes Care announces FDA designation of Basal-IQ technology as an interoperable automated glycemic controller
Feb 20, 2020: Data presented at International Diabetes Conference further demonstrate benefits of Tandem Diabetes care automated insulin delivery technologies
Feb 05, 2020: Tandem Diabetes Care recalls t:slim X2 insulin pump
Jan 15, 2020: Tandem Diabetes Care announces commercial launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States
Jan 09, 2020: Tandem Diabetes Care appoints new executive vice president of strategy and corporate development
Jan 02, 2020: FDA approves UVA-developed artificial pancreas
Dec 23, 2019: Dexcom Partners with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain
Dec 13, 2019: Tandem Diabetes Care announces FDA clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
Dec 13, 2019: FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system
Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Tandem Diabetes Care Inc Pipeline Products by Equipment Type
Tandem Diabetes Care Inc Pipeline Products by Indication
Tandem Diabetes Care Inc, Key Facts
Tandem Diabetes Care Inc, Major Products and Services
Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
AutoSoft XC - Product Status
AutoSoft XC - Product Description
Next Generation Gswim - Product Status
Next Generation Gswim - Product Description
t:connect Mobile - Biometric Authentication - Product Status
t:connect Mobile - Biometric Authentication - Product Description
t:connect Mobile - Decision Support - Product Status
t:connect Mobile - Decision Support - Product Description
t:connect Mobile - Health App Integration - Product Status
t:connect Mobile - Health App Integration - Product Description
t:connect Mobile - Mobile Bolus - Product Status
t:connect Mobile - Mobile Bolus - Product Description
t:sport - Product Status
t:sport - Product Description
Tandem Diabetes Care Inc, Key Employees
Tandem Diabetes Care Inc, Subsidiaries
Glossary

★海外企業調査レポート[Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Toshiba Corporation (6502):企業の財務・戦略的SWOT分析
    Toshiba Corporation (6502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Lawson, Inc.:企業の戦略・SWOT・財務情報
    Lawson, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lawson, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nizhnekamskneftekhim (NKNC):企業の財務・戦略的SWOT分析
    Nizhnekamskneftekhim (NKNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • Hanwha Life Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Nova Eye Medical Ltd (EYE):企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hyundai Marine & Fire Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Hyundai Marine & Fire Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hyundai Marine & Fire Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company’s manufactures products for analgesic and antipyretic, antibiotic, anticoagulant, disinfectant and antiseptic, iron supplement, neurology, …
  • Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Insurance Corporation Of British Columbia:企業の戦略・SWOT・財務情報
    Insurance Corporation Of British Columbia - Strategy, SWOT and Corporate Finance Report Summary Insurance Corporation Of British Columbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose), formerly Wheelmark Plc is an investment company that offers buy, improve and sell manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipments. Its business portfo …
  • Heron Therapeutics Inc (HRTX):医療機器:M&Aディール及び事業提携情報
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-base …
  • Dongkook Pharmaceutical Co Ltd (086450)-製薬・医療分野:企業M&A・提携分析
    Summary Dongkook Pharmaceutical Co Ltd (Dongkook) formerly known as UEC & Co. Ltd, is a pharmaceutical company which develops, manufacture and distributes pharmaceutical products, health care products and medical devices. It offers pharmaceutical products such as antibiotics, anodynes, vitamins, wou …
  • Carl Zeiss Meditec Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec Inc (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a medical technology company that manufactures and markets various healthcare products. The company provides ophthalmology and optometry products, neurosurgery products, ENT products, spine surgery products …
  • American Greetings Corporation (AM):企業の戦略的SWOT分析
    American Greetings Corporation (AM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆